# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-25-108840
Filing Date
2025-11-10
Accepted
2025-11-10 08:00:35
Documents
14
Period of Report
2025-11-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2530721d1_8k.htm iXBRL | 8-K | 25627
2 | EXHIBIT 99.1 | tm2530721d1_ex99-1.htm | EX-99.1 | 7637
6 | GRAPHIC | tm2530721d1_ex99-1img001.jpg | GRAPHIC | 1506832
| Complete submission text file | 0001104659-25-108840.txt |  | 2277310

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | btai-20251110.xsd | EX-101.SCH | 3047
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | btai-20251110_lab.xml | EX-101.LAB | 34239
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | btai-20251110_pre.xml | EX-101.PRE | 22380
16 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2530721d1_8k_htm.xml | XML | 3562

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 251464425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)